Development of 2, 4-diaminoquinazoline derivatives as potent PAK4 inhibitors by the core refinement strategy
摘要:
Upon analysis of the reported crystal structure of PAK4 inhibitor KY04031 (PAK4 IC50 = 0.790 mu M) in the active site of PAK4, we investigated the possibility of changing the triazine core of KY04031 to a quinazoline. Using KY04031 as a starting compound, a library of 2, 4-diaminoquinazoline derivatives were designed and synthesized. These compounds were evaluated for PAK4 inhibition, leading to the identification of compound 9d (PAK4 IC50 = 0.033 mu M). Compound 9d significantly induced the cell cycle in the G1/S phase and inhibited migration and invasion of A549 cells that over-express PAK4 via regulation of the PAK4-LIMK1 signalling pathway. A docking study of compound 9d was performed to elucidate its possible binding modes and to provide a structural basis for further structure-guided design of PAK4 inhibitors. Compound 9d may serve as a lead compound for anticancer drug discovery and as a valuable research probe for further biological investigation of PAK4. (C) 2017 Published by Elsevier Masson SAS.
Ruechardt, Christoph; Hassmann, Volker, Liebigs Annalen der Chemie, 1980, # 6, p. 908 - 927
作者:Ruechardt, Christoph、Hassmann, Volker
DOI:——
日期:——
WO2021007477A5
申请人:——
公开号:WO2021007477A5
公开(公告)日:2023-07-19
Brotzeller, Uwe; Nyitrai, Jozsef; Musso, Hans, Chemische Berichte, 1980, vol. 113, # 11, p. 3610 - 3620
作者:Brotzeller, Uwe、Nyitrai, Jozsef、Musso, Hans
DOI:——
日期:——
Buchwald reaction as the key step for the synthesis of metabolically more stable analogs of amodiaquine
作者:Nicolas Le Fur、Guillaume Hochart、Paul-Emmanuel Larchanché、Patricia Melnyk
DOI:10.1016/j.ejmech.2011.04.047
日期:2011.7
Amodiaquine is one of the most active anti-malarial 4-aminoquinoline but its metabolization is believed to generate hepatotoxic derivatives. Previously, we described new analogs of amodiaquine and amopyroquine, in which hydroxyl group was replaced by various amino groups and identified highly potent compounds with lower toxicity. We describe here the synthesis of new analogs that have been modified on their 4'- and 5'-positions in order to reduce their metabolization. A new synthetic strategy was developed using Buchwald coupling reaction as the key step. (C) 2011 Elsevier Masson SAS. All rights reserved.
RUECHARDT C.; HASSMANN V., LIEBIGS ANN. CHEM., 1980, NO 6, 908-927